Veterinary parasitology · 2008
Protective immunity of recombinant Mycobacterium bovis BCG expressing rhomboid gene against Eimeria tenella challenge.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Qiuyue, Li Jianhua, Zhang Xichen, Liu Quan, Liu Chengwu, Ma Guangpeng, Cao Lili, Gong Pengtao, Cai Yanan, Zhang Guocai
Аннотация
Two recombinant Mycobacterium bovis BCG (rBCG) strains carrying the Eimeria tenella rhomboid gene (Rho) delivered by extrachromosomal vector pMV261 and integrative vector pMV361 were evaluated for their ability to protect chickens against E. tenella challenge. The chickens were immunized intranasal with BCG, rBCG pMV261-Rho, or rBCG pMV361-Rho twice at a 2-week interval. All the recombinant BCG immunized chickens developed specific immune responses, and there was a significant increases of the percentages of CD4(+) and CD8(+) cells compared to the control (P<0.05). Challenge experiments demonstrated that the two rBCG strains could provide significant protection against E. tenella challenge. But vaccination with rBCG pMV261-Rho induced higher specific antibody titers and produced greater protection rate (56.04%) than rBCG pMV361-Rho group (P<0.05). These results indicated that M. bovis BCG is a novel vaccine vector to express and present antigens of E. tenella, and rBCG has a potential as vaccine in chickens.
Предметные рубрики MeSH
AnimalsAntibodies, ProtozoanBCG VaccineCD4-CD8 RatioCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesChickensCoccidiosisEimeria tenellaGene ExpressionGenetic VectorsImmunity, CellularLymphocyte ActivationLymphocyte CountMycobacterium bovisPoultry DiseasesRandom AllocationSpecific Pathogen-Free OrganismsVaccinationVaccines, Synthetic